NLRP3 and metabolic dysfunction-associated steatotic liver disease: During the pathogenesis of NAFLD, liver fibrosis, and cirrhosis, the activation of NLRP3 inflammasome accelerates the pathological progression aggravating the symptoms of liver diseases on human body.